Evidence map›Paper›PMID 38882452›Full record

ArticleMediterranean journal of hematology and infectious diseases2024

Antiviral and Monoclonal Antibody Combination Therapy in Haematological Patients in the Omicron Era.

Serena Vita, Emanuela Giombini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi and 7 more

Abstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Serena VitaNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Emanuela GiombiniNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Patrizia De MarcoNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Martina RuecaNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Cesare Ernesto Maria GruberNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Alessia BeccaceceNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Laura ScorzoliniNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Valentina MazzottaNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Carmen PinnettiNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Priscilla CaputiNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Daniele FocosiNorth-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Enrico GirardiNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Andrea AntinoriNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Fabrizio MaggiNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Alessandra D'AbramoNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Emanuele NicastriNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
Spallanzani COVID-19 case investigation team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntiviralsImmunocompromisedMonoclonal antibodiesPersistent infectionSARS-CoV-2 infectionViral evolution

Identifiers

PMID38882452
PMCPMC11178048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.